nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CYP1A1—chronic obstructive pulmonary disease	0.29	1	CbGaD
Tretinoin—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0687	0.183	CbGbCtD
Tretinoin—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0687	0.183	CbGbCtD
Tretinoin—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0521	0.139	CbGbCtD
Tretinoin—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0305	0.0814	CbGbCtD
Tretinoin—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0257	0.0684	CbGbCtD
Tretinoin—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0236	0.063	CbGbCtD
Tretinoin—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0236	0.063	CbGbCtD
Tretinoin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0181	0.0483	CbGbCtD
Tretinoin—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0179	0.0477	CbGbCtD
Tretinoin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0122	0.0326	CbGbCtD
Tretinoin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0117	0.0311	CbGbCtD
Tretinoin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0104	0.0278	CbGbCtD
Tretinoin—GPRC5A—respiratory system—chronic obstructive pulmonary disease	0.00654	0.101	CbGeAlD
Tretinoin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00611	0.0163	CbGbCtD
Tretinoin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00577	0.0154	CbGbCtD
Tretinoin—GPRC5A—lung—chronic obstructive pulmonary disease	0.00347	0.0539	CbGeAlD
Tretinoin—NR0B1—respiratory system—chronic obstructive pulmonary disease	0.00285	0.0441	CbGeAlD
Tretinoin—RARRES1—bronchus—chronic obstructive pulmonary disease	0.00272	0.0422	CbGeAlD
Tretinoin—ALDH1A2—respiratory system—chronic obstructive pulmonary disease	0.00254	0.0394	CbGeAlD
Tretinoin—RARRES1—trachea—chronic obstructive pulmonary disease	0.00244	0.0379	CbGeAlD
Tretinoin—CRABP1—connective tissue—chronic obstructive pulmonary disease	0.00215	0.0334	CbGeAlD
Tretinoin—CRABP1—bronchus—chronic obstructive pulmonary disease	0.00201	0.0312	CbGeAlD
Tretinoin—RARB—respiratory system—chronic obstructive pulmonary disease	0.00198	0.0307	CbGeAlD
Tretinoin—CRABP2—connective tissue—chronic obstructive pulmonary disease	0.00195	0.0302	CbGeAlD
Tretinoin—ALDH1A1—respiratory system—chronic obstructive pulmonary disease	0.00184	0.0286	CbGeAlD
Tretinoin—CRABP2—bronchus—chronic obstructive pulmonary disease	0.00182	0.0283	CbGeAlD
Tretinoin—CRABP1—trachea—chronic obstructive pulmonary disease	0.00181	0.0281	CbGeAlD
Tretinoin—CRABP2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00178	0.0276	CbGeAlD
Tretinoin—RARRES1—lung—chronic obstructive pulmonary disease	0.00176	0.0272	CbGeAlD
Tretinoin—CRABP2—trachea—chronic obstructive pulmonary disease	0.00164	0.0254	CbGeAlD
Tretinoin—RARB—bronchus—chronic obstructive pulmonary disease	0.00163	0.0253	CbGeAlD
Tretinoin—ALDH1A1—connective tissue—chronic obstructive pulmonary disease	0.00162	0.0252	CbGeAlD
Tretinoin—RARG—respiratory system—chronic obstructive pulmonary disease	0.00161	0.025	CbGeAlD
Tretinoin—RARA—respiratory system—chronic obstructive pulmonary disease	0.00152	0.0235	CbGeAlD
Tretinoin—ALDH1A1—bronchus—chronic obstructive pulmonary disease	0.00152	0.0235	CbGeAlD
Tretinoin—NR0B1—lung—chronic obstructive pulmonary disease	0.00151	0.0234	CbGeAlD
Tretinoin—ALDH1A1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00148	0.023	CbGeAlD
Tretinoin—ALDH1A1—trachea—chronic obstructive pulmonary disease	0.00136	0.0211	CbGeAlD
Tretinoin—ALDH1A2—lung—chronic obstructive pulmonary disease	0.00135	0.0209	CbGeAlD
Tretinoin—CYP2C18—bronchus—chronic obstructive pulmonary disease	0.00133	0.0207	CbGeAlD
Tretinoin—CRABP2—lung—chronic obstructive pulmonary disease	0.00118	0.0182	CbGeAlD
Tretinoin—RARB—lung—chronic obstructive pulmonary disease	0.00105	0.0163	CbGeAlD
Tretinoin—Alitretinoin—CYP1A2—chronic obstructive pulmonary disease	0.00103	0.424	CrCbGaD
Tretinoin—ALDH1A1—lung—chronic obstructive pulmonary disease	0.000979	0.0152	CbGeAlD
Tretinoin—RXRB—lung—chronic obstructive pulmonary disease	0.000966	0.015	CbGeAlD
Tretinoin—RARG—lung—chronic obstructive pulmonary disease	0.000857	0.0133	CbGeAlD
Tretinoin—RARA—lung—chronic obstructive pulmonary disease	0.000806	0.0125	CbGeAlD
Tretinoin—Vitamin A—CYP1A1—chronic obstructive pulmonary disease	0.000783	0.321	CrCbGaD
Tretinoin—Acitretin—ALB—chronic obstructive pulmonary disease	0.000623	0.255	CrCbGaD
Tretinoin—CYP2A6—lung—chronic obstructive pulmonary disease	0.000569	0.00883	CbGeAlD
Tretinoin—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000555	0.00861	CbGeAlD
Tretinoin—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000543	0.00842	CbGeAlD
Tretinoin—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000539	0.00837	CbGeAlD
Tretinoin—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000457	0.00709	CbGeAlD
Tretinoin—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000444	0.00689	CbGeAlD
Tretinoin—CYP1A1—trachea—chronic obstructive pulmonary disease	0.00041	0.00636	CbGeAlD
Tretinoin—CYP1A1—lung—chronic obstructive pulmonary disease	0.000295	0.00457	CbGeAlD
Tretinoin—CYP3A5—lung—chronic obstructive pulmonary disease	0.000288	0.00447	CbGeAlD
Tretinoin—CYP2B6—lung—chronic obstructive pulmonary disease	0.000286	0.00444	CbGeAlD
Tretinoin—Infection—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000759	CcSEcCtD
Tretinoin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.000758	CcSEcCtD
Tretinoin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000131	0.000758	CcSEcCtD
Tretinoin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.000755	CcSEcCtD
Tretinoin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000751	CcSEcCtD
Tretinoin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000129	0.000749	CcSEcCtD
Tretinoin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000129	0.000748	CcSEcCtD
Tretinoin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000748	CcSEcCtD
Tretinoin—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000747	CcSEcCtD
Tretinoin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000128	0.000742	CcSEcCtD
Tretinoin—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000739	CcSEcCtD
Tretinoin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000736	CcSEcCtD
Tretinoin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000736	CcSEcCtD
Tretinoin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.000732	CcSEcCtD
Tretinoin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.000729	CcSEcCtD
Tretinoin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000126	0.000729	CcSEcCtD
Tretinoin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000728	CcSEcCtD
Tretinoin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000125	0.000725	CcSEcCtD
Tretinoin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000725	CcSEcCtD
Tretinoin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.000724	CcSEcCtD
Tretinoin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000722	CcSEcCtD
Tretinoin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.000719	CcSEcCtD
Tretinoin—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000718	CcSEcCtD
Tretinoin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000715	CcSEcCtD
Tretinoin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000123	0.000712	CcSEcCtD
Tretinoin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000712	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000123	0.000711	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.000711	CcSEcCtD
Tretinoin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000705	CcSEcCtD
Tretinoin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000705	CcSEcCtD
Tretinoin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000702	CcSEcCtD
Tretinoin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000121	0.000701	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000696	CcSEcCtD
Tretinoin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000695	CcSEcCtD
Tretinoin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000695	CcSEcCtD
Tretinoin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000693	CcSEcCtD
Tretinoin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000693	CcSEcCtD
Tretinoin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000119	0.000691	CcSEcCtD
Tretinoin—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000689	CcSEcCtD
Tretinoin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000688	CcSEcCtD
Tretinoin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000687	CcSEcCtD
Tretinoin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000687	CcSEcCtD
Tretinoin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000118	0.000686	CcSEcCtD
Tretinoin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000118	0.000684	CcSEcCtD
Tretinoin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000679	CcSEcCtD
Tretinoin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000117	0.000678	CcSEcCtD
Tretinoin—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000676	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000673	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000673	CcSEcCtD
Tretinoin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000672	CcSEcCtD
Tretinoin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000672	CcSEcCtD
Tretinoin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000672	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000671	CcSEcCtD
Tretinoin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000115	0.000667	CcSEcCtD
Tretinoin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000115	0.000667	CcSEcCtD
Tretinoin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.000667	CcSEcCtD
Tretinoin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.000667	CcSEcCtD
Tretinoin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000666	CcSEcCtD
Tretinoin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000661	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000659	CcSEcCtD
Tretinoin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000659	CcSEcCtD
Tretinoin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000657	CcSEcCtD
Tretinoin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000655	CcSEcCtD
Tretinoin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000113	0.000653	CcSEcCtD
Tretinoin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000653	CcSEcCtD
Tretinoin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000112	0.000652	CcSEcCtD
Tretinoin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000649	CcSEcCtD
Tretinoin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000649	CcSEcCtD
Tretinoin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000648	CcSEcCtD
Tretinoin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000111	0.000646	CcSEcCtD
Tretinoin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000111	0.000646	CcSEcCtD
Tretinoin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000644	CcSEcCtD
Tretinoin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000643	CcSEcCtD
Tretinoin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000643	CcSEcCtD
Tretinoin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000111	0.000642	CcSEcCtD
Tretinoin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.00064	CcSEcCtD
Tretinoin—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00064	CcSEcCtD
Tretinoin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00011	0.000639	CcSEcCtD
Tretinoin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00011	0.000638	CcSEcCtD
Tretinoin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.000638	CcSEcCtD
Tretinoin—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000637	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000636	CcSEcCtD
Tretinoin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.000635	CcSEcCtD
Tretinoin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00063	CcSEcCtD
Tretinoin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00063	CcSEcCtD
Tretinoin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000108	0.000625	CcSEcCtD
Tretinoin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000624	CcSEcCtD
Tretinoin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000624	CcSEcCtD
Tretinoin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000107	0.00062	CcSEcCtD
Tretinoin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.00062	CcSEcCtD
Tretinoin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000617	CcSEcCtD
Tretinoin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000617	CcSEcCtD
Tretinoin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000617	CcSEcCtD
Tretinoin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000617	CcSEcCtD
Tretinoin—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000615	CcSEcCtD
Tretinoin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000106	0.000614	CcSEcCtD
Tretinoin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00061	CcSEcCtD
Tretinoin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000105	0.000609	CcSEcCtD
Tretinoin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000105	0.000609	CcSEcCtD
Tretinoin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000105	0.000609	CcSEcCtD
Tretinoin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000607	CcSEcCtD
Tretinoin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000607	CcSEcCtD
Tretinoin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000104	0.000605	CcSEcCtD
Tretinoin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000604	CcSEcCtD
Tretinoin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000604	CcSEcCtD
Tretinoin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000603	CcSEcCtD
Tretinoin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.000602	CcSEcCtD
Tretinoin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000598	CcSEcCtD
Tretinoin—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000596	CcSEcCtD
Tretinoin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000595	CcSEcCtD
Tretinoin—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000594	CcSEcCtD
Tretinoin—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000592	CcSEcCtD
Tretinoin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000585	CcSEcCtD
Tretinoin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000582	CcSEcCtD
Tretinoin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000582	CcSEcCtD
Tretinoin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	9.91e-05	0.000575	CcSEcCtD
Tretinoin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	9.91e-05	0.000575	CcSEcCtD
Tretinoin—Nausea—Tiotropium—chronic obstructive pulmonary disease	9.9e-05	0.000574	CcSEcCtD
Tretinoin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	9.88e-05	0.000573	CcSEcCtD
Tretinoin—Dry skin—Prednisone—chronic obstructive pulmonary disease	9.87e-05	0.000572	CcSEcCtD
Tretinoin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	9.7e-05	0.000563	CcSEcCtD
Tretinoin—Asthenia—Formoterol—chronic obstructive pulmonary disease	9.65e-05	0.00056	CcSEcCtD
Tretinoin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	9.65e-05	0.00056	CcSEcCtD
Tretinoin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	9.51e-05	0.000552	CcSEcCtD
Tretinoin—Pruritus—Formoterol—chronic obstructive pulmonary disease	9.51e-05	0.000552	CcSEcCtD
Tretinoin—Asthenia—Montelukast—chronic obstructive pulmonary disease	9.45e-05	0.000548	CcSEcCtD
Tretinoin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.000543	CcSEcCtD
Tretinoin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	9.36e-05	0.000543	CcSEcCtD
Tretinoin—Pruritus—Montelukast—chronic obstructive pulmonary disease	9.32e-05	0.00054	CcSEcCtD
Tretinoin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	9.2e-05	0.000534	CcSEcCtD
Tretinoin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	9.2e-05	0.000534	CcSEcCtD
Tretinoin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	9.16e-05	0.000531	CcSEcCtD
Tretinoin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.000529	CcSEcCtD
Tretinoin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	9.11e-05	0.000528	CcSEcCtD
Tretinoin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	9.07e-05	0.000526	CcSEcCtD
Tretinoin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	9.01e-05	0.000523	CcSEcCtD
Tretinoin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	8.98e-05	0.000521	CcSEcCtD
Tretinoin—Erythema—Prednisolone—chronic obstructive pulmonary disease	8.92e-05	0.000518	CcSEcCtD
Tretinoin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	8.89e-05	0.000516	CcSEcCtD
Tretinoin—Dizziness—Formoterol—chronic obstructive pulmonary disease	8.89e-05	0.000516	CcSEcCtD
Tretinoin—Dizziness—Montelukast—chronic obstructive pulmonary disease	8.71e-05	0.000505	CcSEcCtD
Tretinoin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	8.7e-05	0.000505	CcSEcCtD
Tretinoin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	8.69e-05	0.000504	CcSEcCtD
Tretinoin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	8.55e-05	0.000496	CcSEcCtD
Tretinoin—Vomiting—Formoterol—chronic obstructive pulmonary disease	8.55e-05	0.000496	CcSEcCtD
Tretinoin—Rash—Arformoterol—chronic obstructive pulmonary disease	8.48e-05	0.000492	CcSEcCtD
Tretinoin—Rash—Formoterol—chronic obstructive pulmonary disease	8.48e-05	0.000492	CcSEcCtD
Tretinoin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	8.47e-05	0.000491	CcSEcCtD
Tretinoin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	8.47e-05	0.000491	CcSEcCtD
Tretinoin—Weight increased—Prednisone—chronic obstructive pulmonary disease	8.47e-05	0.000491	CcSEcCtD
Tretinoin—Headache—Formoterol—chronic obstructive pulmonary disease	8.42e-05	0.000489	CcSEcCtD
Tretinoin—Headache—Arformoterol—chronic obstructive pulmonary disease	8.42e-05	0.000489	CcSEcCtD
Tretinoin—Weight decreased—Prednisone—chronic obstructive pulmonary disease	8.42e-05	0.000488	CcSEcCtD
Tretinoin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	8.41e-05	0.000488	CcSEcCtD
Tretinoin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	8.4e-05	0.000487	CcSEcCtD
Tretinoin—Vomiting—Montelukast—chronic obstructive pulmonary disease	8.38e-05	0.000486	CcSEcCtD
Tretinoin—Rash—Montelukast—chronic obstructive pulmonary disease	8.31e-05	0.000482	CcSEcCtD
Tretinoin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	8.3e-05	0.000481	CcSEcCtD
Tretinoin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	8.28e-05	0.00048	CcSEcCtD
Tretinoin—Depression—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.00048	CcSEcCtD
Tretinoin—Headache—Montelukast—chronic obstructive pulmonary disease	8.25e-05	0.000479	CcSEcCtD
Tretinoin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.000474	CcSEcCtD
Tretinoin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000472	CcSEcCtD
Tretinoin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000472	CcSEcCtD
Tretinoin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	8.07e-05	0.000468	CcSEcCtD
Tretinoin—Malaise—Prednisolone—chronic obstructive pulmonary disease	8.05e-05	0.000467	CcSEcCtD
Tretinoin—Rash—Salbutamol—chronic obstructive pulmonary disease	8.01e-05	0.000464	CcSEcCtD
Tretinoin—Syncope—Prednisolone—chronic obstructive pulmonary disease	8e-05	0.000464	CcSEcCtD
Tretinoin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	8e-05	0.000464	CcSEcCtD
Tretinoin—Nausea—Formoterol—chronic obstructive pulmonary disease	7.99e-05	0.000463	CcSEcCtD
Tretinoin—Nausea—Arformoterol—chronic obstructive pulmonary disease	7.99e-05	0.000463	CcSEcCtD
Tretinoin—Headache—Salbutamol—chronic obstructive pulmonary disease	7.96e-05	0.000461	CcSEcCtD
Tretinoin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	7.84e-05	0.000455	CcSEcCtD
Tretinoin—Nausea—Montelukast—chronic obstructive pulmonary disease	7.82e-05	0.000454	CcSEcCtD
Tretinoin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	7.73e-05	0.000448	CcSEcCtD
Tretinoin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	7.7e-05	0.000447	CcSEcCtD
Tretinoin—Nausea—Salbutamol—chronic obstructive pulmonary disease	7.54e-05	0.000437	CcSEcCtD
Tretinoin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	7.51e-05	0.000435	CcSEcCtD
Tretinoin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	7.49e-05	0.000434	CcSEcCtD
Tretinoin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	7.45e-05	0.000432	CcSEcCtD
Tretinoin—Hallucination—Prednisone—chronic obstructive pulmonary disease	7.41e-05	0.00043	CcSEcCtD
Tretinoin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	7.28e-05	0.000422	CcSEcCtD
Tretinoin—Oedema—Prednisolone—chronic obstructive pulmonary disease	7.28e-05	0.000422	CcSEcCtD
Tretinoin—Shock—Prednisolone—chronic obstructive pulmonary disease	7.17e-05	0.000416	CcSEcCtD
Tretinoin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	7.11e-05	0.000412	CcSEcCtD
Tretinoin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	7.04e-05	0.000408	CcSEcCtD
Tretinoin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	6.96e-05	0.000404	CcSEcCtD
Tretinoin—Flushing—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000401	CcSEcCtD
Tretinoin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	6.76e-05	0.000392	CcSEcCtD
Tretinoin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	6.65e-05	0.000386	CcSEcCtD
Tretinoin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	6.59e-05	0.000382	CcSEcCtD
Tretinoin—Alopecia—Prednisone—chronic obstructive pulmonary disease	6.58e-05	0.000382	CcSEcCtD
Tretinoin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.54e-05	0.000379	CcSEcCtD
Tretinoin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	6.53e-05	0.000378	CcSEcCtD
Tretinoin—Erythema—Prednisone—chronic obstructive pulmonary disease	6.48e-05	0.000376	CcSEcCtD
Tretinoin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	6.48e-05	0.000376	CcSEcCtD
Tretinoin—Pain—Prednisolone—chronic obstructive pulmonary disease	6.23e-05	0.000361	CcSEcCtD
Tretinoin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	6.11e-05	0.000354	CcSEcCtD
Tretinoin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000349	CcSEcCtD
Tretinoin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6e-05	0.000348	CcSEcCtD
Tretinoin—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.99e-05	0.000348	CcSEcCtD
Tretinoin—Agitation—Prednisone—chronic obstructive pulmonary disease	5.96e-05	0.000346	CcSEcCtD
Tretinoin—Malaise—Prednisone—chronic obstructive pulmonary disease	5.85e-05	0.000339	CcSEcCtD
Tretinoin—Syncope—Prednisone—chronic obstructive pulmonary disease	5.82e-05	0.000337	CcSEcCtD
Tretinoin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.79e-05	0.000336	CcSEcCtD
Tretinoin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.7e-05	0.000331	CcSEcCtD
Tretinoin—Convulsion—Prednisone—chronic obstructive pulmonary disease	5.62e-05	0.000326	CcSEcCtD
Tretinoin—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.6e-05	0.000325	CcSEcCtD
Tretinoin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.00032	CcSEcCtD
Tretinoin—Myalgia—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.00032	CcSEcCtD
Tretinoin—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000319	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.48e-05	0.000318	CcSEcCtD
Tretinoin—Discomfort—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.000316	CcSEcCtD
Tretinoin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.37e-05	0.000311	CcSEcCtD
Tretinoin—Oedema—Prednisone—chronic obstructive pulmonary disease	5.29e-05	0.000307	CcSEcCtD
Tretinoin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	5.29e-05	0.000307	CcSEcCtD
Tretinoin—Infection—Prednisone—chronic obstructive pulmonary disease	5.26e-05	0.000305	CcSEcCtD
Tretinoin—Shock—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.000302	CcSEcCtD
Tretinoin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.19e-05	0.000301	CcSEcCtD
Tretinoin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.17e-05	0.0003	CcSEcCtD
Tretinoin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.14e-05	0.000298	CcSEcCtD
Tretinoin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.12e-05	0.000297	CcSEcCtD
Tretinoin—Anorexia—Prednisone—chronic obstructive pulmonary disease	5.04e-05	0.000293	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.82e-05	0.00028	CcSEcCtD
Tretinoin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.82e-05	0.000279	CcSEcCtD
Tretinoin—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.79e-05	0.000278	CcSEcCtD
Tretinoin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.75e-05	0.000276	CcSEcCtD
Tretinoin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.00027	CcSEcCtD
Tretinoin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.000267	CcSEcCtD
Tretinoin—Rash—Prednisolone—chronic obstructive pulmonary disease	4.59e-05	0.000266	CcSEcCtD
Tretinoin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.59e-05	0.000266	CcSEcCtD
Tretinoin—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.56e-05	0.000265	CcSEcCtD
Tretinoin—Headache—Prednisolone—chronic obstructive pulmonary disease	4.56e-05	0.000265	CcSEcCtD
Tretinoin—Constipation—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.000262	CcSEcCtD
Tretinoin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.36e-05	0.000253	CcSEcCtD
Tretinoin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.33e-05	0.000251	CcSEcCtD
Tretinoin—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.33e-05	0.000251	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.32e-05	0.000454	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.32e-05	0.000454	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	4.27e-05	0.000449	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	4.26e-05	0.000448	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—HDAC2—chronic obstructive pulmonary disease	4.26e-05	0.000448	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.26e-05	0.000448	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.22e-05	0.000444	CbGpPWpGaD
Tretinoin—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.2e-05	0.000244	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.18e-05	0.00044	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.18e-05	0.00044	CbGpPWpGaD
Tretinoin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.18e-05	0.000243	CcSEcCtD
Tretinoin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.18e-05	0.000243	CcSEcCtD
Tretinoin—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.17e-05	0.000438	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.16e-05	0.000437	CbGpPWpGaD
Tretinoin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.15e-05	0.000436	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.15e-05	0.000436	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GC—chronic obstructive pulmonary disease	4.14e-05	0.000436	CbGpPWpGaD
Tretinoin—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.11e-05	0.000432	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.1e-05	0.000431	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.1e-05	0.000431	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.1e-05	0.000431	CbGpPWpGaD
Tretinoin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.09e-05	0.00043	CbGpPWpGaD
Tretinoin—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.09e-05	0.00043	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.05e-05	0.000426	CbGpPWpGaD
Tretinoin—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4e-05	0.00042	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.93e-05	0.000413	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	3.92e-05	0.000412	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	3.9e-05	0.00041	CbGpPWpGaD
Tretinoin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.9e-05	0.000226	CcSEcCtD
Tretinoin—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.88e-05	0.000407	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.87e-05	0.000407	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.86e-05	0.000406	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.85e-05	0.000405	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.84e-05	0.000404	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.83e-05	0.000403	CbGpPWpGaD
Tretinoin—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.83e-05	0.000402	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.82e-05	0.000401	CbGpPWpGaD
Tretinoin—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.8e-05	0.00022	CcSEcCtD
Tretinoin—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.79e-05	0.000398	CbGpPWpGaD
Tretinoin—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.78e-05	0.000397	CbGpPWpGaD
Tretinoin—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.77e-05	0.000396	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GC—chronic obstructive pulmonary disease	3.76e-05	0.000395	CbGpPWpGaD
Tretinoin—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.74e-05	0.000217	CcSEcCtD
Tretinoin—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.73e-05	0.000392	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.68e-05	0.000386	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—TNF—chronic obstructive pulmonary disease	3.64e-05	0.000383	CbGpPWpGaD
Tretinoin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.62e-05	0.00021	CcSEcCtD
Tretinoin—RXRA—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.55e-05	0.000374	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.51e-05	0.000369	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.51e-05	0.000369	CbGpPWpGaD
Tretinoin—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.5e-05	0.000203	CcSEcCtD
Tretinoin—RXRA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.5e-05	0.000367	CbGpPWpGaD
Tretinoin—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.46e-05	0.000364	CbGpPWpGaD
Tretinoin—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.37e-05	0.000195	CcSEcCtD
Tretinoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.36e-05	0.000353	CbGpPWpGaD
Tretinoin—Rash—Prednisone—chronic obstructive pulmonary disease	3.34e-05	0.000194	CcSEcCtD
Tretinoin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.33e-05	0.000193	CcSEcCtD
Tretinoin—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.33e-05	0.00035	CbGpPWpGaD
Tretinoin—Headache—Prednisone—chronic obstructive pulmonary disease	3.32e-05	0.000192	CcSEcCtD
Tretinoin—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.28e-05	0.000345	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	3.16e-05	0.000332	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.15e-05	0.000331	CbGpPWpGaD
Tretinoin—Nausea—Prednisone—chronic obstructive pulmonary disease	3.14e-05	0.000182	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.12e-05	0.000328	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.11e-05	0.000327	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	3.09e-05	0.000325	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.07e-05	0.000322	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	3.01e-05	0.000316	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3e-05	0.000315	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.96e-05	0.000311	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—IL6—chronic obstructive pulmonary disease	2.94e-05	0.000309	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.92e-05	0.000307	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	2.92e-05	0.000307	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.87e-05	0.000301	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.86e-05	0.0003	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.83e-05	0.000298	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.82e-05	0.000296	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.81e-05	0.000296	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ALB—chronic obstructive pulmonary disease	2.78e-05	0.000293	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.78e-05	0.000293	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ALB—chronic obstructive pulmonary disease	2.78e-05	0.000293	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.78e-05	0.000293	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	2.75e-05	0.00029	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.71e-05	0.000285	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—LEP—chronic obstructive pulmonary disease	2.71e-05	0.000284	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.68e-05	0.000281	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	2.68e-05	0.000281	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.67e-05	0.000281	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.66e-05	0.00028	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.66e-05	0.00028	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.66e-05	0.00028	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.6e-05	0.000273	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.59e-05	0.000272	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.56e-05	0.000269	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GCLC—chronic obstructive pulmonary disease	2.56e-05	0.000269	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	2.52e-05	0.000265	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.46e-05	0.000258	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.42e-05	0.000255	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.42e-05	0.000255	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	2.39e-05	0.000251	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.39e-05	0.000251	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.38e-05	0.00025	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.36e-05	0.000248	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.35e-05	0.000247	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CTGF—chronic obstructive pulmonary disease	2.34e-05	0.000246	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.26e-05	0.000238	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.26e-05	0.000237	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GCLC—chronic obstructive pulmonary disease	2.24e-05	0.000235	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.22e-05	0.000233	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.22e-05	0.000233	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.18e-05	0.000229	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.17e-05	0.000229	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.15e-05	0.000226	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.09e-05	0.00022	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.08e-05	0.000219	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.08e-05	0.000219	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.08e-05	0.000219	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.05e-05	0.000216	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.05e-05	0.000215	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.05e-05	0.000215	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CTGF—chronic obstructive pulmonary disease	2.04e-05	0.000215	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.04e-05	0.000214	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GCLC—chronic obstructive pulmonary disease	2.03e-05	0.000213	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.02e-05	0.000212	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	1.99e-05	0.000209	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.93e-05	0.000203	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.92e-05	0.000202	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.91e-05	0.000201	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.89e-05	0.000199	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.89e-05	0.000199	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.88e-05	0.000198	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.88e-05	0.000198	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.88e-05	0.000198	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.86e-05	0.000195	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CTGF—chronic obstructive pulmonary disease	1.85e-05	0.000195	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.85e-05	0.000195	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.8e-05	0.000189	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.79e-05	0.000189	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.79e-05	0.000188	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.77e-05	0.000186	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.77e-05	0.000186	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.76e-05	0.000185	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.76e-05	0.000185	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.75e-05	0.000184	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.72e-05	0.000181	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.71e-05	0.000179	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.65e-05	0.000173	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.63e-05	0.000171	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.6e-05	0.000169	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.57e-05	0.000165	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.56e-05	0.000164	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.000163	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.55e-05	0.000163	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.5e-05	0.000158	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.49e-05	0.000156	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.46e-05	0.000154	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.44e-05	0.000152	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.44e-05	0.000152	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.44e-05	0.000151	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.00015	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.42e-05	0.00015	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.4e-05	0.000148	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.4e-05	0.000148	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.38e-05	0.000145	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.37e-05	0.000144	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.36e-05	0.000143	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.36e-05	0.000143	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.34e-05	0.000141	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.31e-05	0.000138	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.31e-05	0.000138	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.3e-05	0.000137	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.28e-05	0.000134	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.25e-05	0.000132	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.25e-05	0.000131	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.24e-05	0.000131	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.00013	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.15e-05	0.00012	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.11e-05	0.000117	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.1e-05	0.000116	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.000114	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.09e-05	0.000114	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000113	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000112	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.04e-05	0.00011	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000109	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.03e-05	0.000108	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.000108	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—NOS3—chronic obstructive pulmonary disease	1.02e-05	0.000107	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	0.000107	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.01e-05	0.000106	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1e-05	0.000106	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	9.81e-06	0.000103	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.59e-06	0.000101	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.56e-06	0.0001	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.52e-06	0.0001	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.47e-06	9.96e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.43e-06	9.91e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.42e-06	9.9e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	9.31e-06	9.79e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	9.29e-06	9.77e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.27e-06	9.74e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	9.26e-06	9.73e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.25e-06	9.72e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.09e-06	9.55e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.04e-06	9.5e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	8.89e-06	9.34e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.79e-06	9.24e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.68e-06	9.13e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.61e-06	9.05e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.54e-06	8.98e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	8.5e-06	8.93e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ALB—chronic obstructive pulmonary disease	8.43e-06	8.86e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.33e-06	8.75e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—NOS3—chronic obstructive pulmonary disease	8.06e-06	8.48e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.83e-06	8.23e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.71e-06	8.11e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.67e-06	8.06e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.61e-06	8e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	7.58e-06	7.97e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.54e-06	7.93e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.44e-06	7.82e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.12e-06	7.49e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.09e-06	7.45e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.07e-06	7.43e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.03e-06	7.38e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.93e-06	7.28e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	6.92e-06	7.27e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.72e-06	7.06e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.57e-06	6.9e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.55e-06	6.88e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.53e-06	6.86e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.44e-06	6.77e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.37e-06	6.7e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	6.18e-06	6.49e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	6e-06	6.31e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	5.91e-06	6.21e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.69e-06	5.98e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	5.66e-06	5.95e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.42e-06	5.69e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.32e-06	5.59e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.24e-06	5.51e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.06e-06	5.32e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5e-06	5.25e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.88e-06	5.13e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.63e-06	4.87e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	4.57e-06	4.8e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.56e-06	4.79e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	4.46e-06	4.69e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.37e-06	4.59e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	4.27e-06	4.49e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.22e-06	4.43e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.2e-06	4.42e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.03e-06	4.24e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.87e-06	4.07e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.7e-06	3.89e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.51e-06	3.68e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.46e-06	3.63e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.22e-06	3.39e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.15e-06	3.31e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.05e-06	3.21e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.01e-06	3.16e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.08e-06	2.18e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.99e-06	2.09e-05	CbGpPWpGaD
